Research & Development

Innovative VOC breath diagnostic technology through joint research with universities and medical institutions in Japan and abroad

MediScan is engaged in the research and development of non-invasive testing technologies that enable the early detection of various cancers, including breast cancer, through advanced analysis of volatile organic compounds (VOCs) present in exhaled breath.
By conducting joint research with universities and medical institutions both in Japan and overseas, we aim to make these tests more accessible and easier to continue, promoting their widespread use in clinical practice.

VOCs Breath Analysis Technology

Feature 01

Biomarker Identification Technology Using AI and
Proprietary Algorithms

Human breath contains 80% nitrogen, 16% oxygen, and 4% carbon dioxide among other gases, and contains approximately 5,000 different VOCs as trace components. We detect hundreds of VOCs using GC/MS. By using AI and proprietary algorithms, we have successfully identified multiple biomarkers. We have achieved a technology that can be detected from stage 0.

Feature 02

High-Precision Detection by(Gas Chromatography Mass Spectrometry)

We conduct a clinical trial approved by the IRB (Institutional Review Board) at Showa University Hospital. Through a trial with a total of 675 samples, we have demonstrated high accuracy with a sensitivity of 91.6% and specificity of 89.3% in the Pilot Test. We have also conducted clinical trials at Tel Aviv University in Israel, achieving a sensitivity of 85% and specificity of 86%.

Feature 03

Dedicated Testing System(Collaboration between MC Nipatec and ArkMS)

MC Nipatec Co., Ltd. (Kobe Steel Group) conducts GC/MS testing. ArkMS Inc. operates as a CRO (Contract Research Organization), providing clinical trial-related services and pharmaceutical consulting.

Research Partners

Sadako Akashi

Professor & Director of the Department of Breast Surgery
Division of Breast Surgery, Department of Surgery, Tokyo Women's Medical University

Professor Akashi is a professor and the director of the Department of Breast Surgery at Tokyo Women's Medical University. She is also the director of the Division of Breast Surgery, Department of Surgery. She has been engaged in research on breast cancer for many years and has published many papers in international journals.